Wright Medical Group and Tornier NV have won U.S. antitrust approval for their merger on condition that they sell certain assets related to replacement ankle and toe joints, the Federal Trade Commission said on Wednesday.
The companies said when the deal was announced in October 2014 that the proposed transaction would create a company with a combined value of about $3.3 billion.
The deal will be allowed to go ahead on condition that the companies sell Tornier’s U.S. rights and assets related to total ankle replacements and total silastic toe joint replacements used to treat arthritis, the FTC said.
The FTC said that it required the divestitures because Wright has 44 percent of the market for the ankle replacements and Tornier has about 19 percent. They also have big shares of the market to make silastic toe joint replacements, the FTC said.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI